Tata Chemicals Reports Mixed Q2 Results, Approves ₹1,500 Crore Fund Raising
Tata Chemicals Limited (TCL) reported mixed Q2 results with consolidated revenue down 3.05% to ₹3,877 crore and profit falling 42.32% to ₹154 crore. Standalone performance improved with revenue up 19.33% to ₹1,204 crore and profit increasing 79.80% to ₹178 crore. The company's Board approved raising up to ₹1,500 crore through Non-Convertible Debentures. TCL incurred ₹65 crore in expenses related to UK operations closure. Basic Chemistry Products segment revenue was ₹2,979 crore, while Specialty Products contributed ₹903 crore.

*this image is generated using AI for illustrative purposes only.
Tata Chemicals Limited (TCL) has reported a mixed set of financial results for the second quarter, while also announcing plans to raise funds through non-convertible debentures.
Financial Performance
For Q2, Tata Chemicals reported:
| Metric | Q2 2025 | Q2 2024 | YoY Change |
|---|---|---|---|
| Consolidated Revenue | ₹3,877.00 | ₹3,999.00 | -3.05% |
| Consolidated Profit | ₹154.00 | ₹267.00 | -42.32% |
| Standalone Revenue | ₹1,204.00 | ₹1,009.00 | +19.33% |
| Standalone Profit | ₹178.00 | ₹99.00 | +79.80% |
The company's consolidated revenue saw a slight decline, while consolidated profit experienced a significant drop. However, on a standalone basis, both revenue and profit showed substantial growth.
Fund Raising Approval
In a strategic move, Tata Chemicals' Board of Directors has approved raising funds up to ₹1,500.00 crores through Non-Convertible Debentures (NCDs) on a private placement basis. An internal committee has been authorized to finalize the terms of issuance and allotment of these NCDs.
Operational Highlights
- The company recorded additional expenses of ₹65.00 crores related to the closure of Lostock operations in the UK, impacting the quarter's profitability.
- The Basic Chemistry Products segment reported revenue of ₹2,979.00 crores for the quarter.
- The Specialty Products segment contributed ₹903.00 crores to the quarter's revenue.
Management Commentary
R. Mukundan, Managing Director and CEO of Tata Chemicals, stated, "Our Q2 results reflect the challenging global economic environment. While our consolidated numbers were impacted by the closure costs of our UK operations, our standalone performance demonstrates the resilience of our Indian operations. The approval to raise funds through NCDs will provide us with the financial flexibility to pursue our strategic objectives."
Looking Ahead
As Tata Chemicals navigates through a complex global market, the company's focus on its core segments and the decision to raise additional funds indicate a proactive approach to managing its operations and financial position. Investors and market observers will be keenly watching how the company utilizes the proposed fund raise and manages its operational challenges in the coming quarters.
The mixed results highlight the importance of Tata Chemicals' diversified portfolio in maintaining overall stability, even as individual segments face varying market conditions.
Historical Stock Returns for Tata Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.12% | -1.02% | -3.17% | +6.37% | -22.48% | +184.10% |













































